The incidence of lung cancer continues to increase. From patients diagnosed today with lung cancer only 14% will survive five years later. However if lung cancer is detected early the five-year survival can rise from 1% for stage IV to 67% for stage IA. For this reason several methods are investigated for an early detection of the disease to thereby increase the chances of survival. The analytical and statistical approaches described here clearly provide a powerful means of selecting diagnostically significant compounds in expired breath. Applying these procedures to a larger sample population should help confirm refute or expand the significance of the compounds identified in this preliminary study and establish diagnostic criteria for general use. The classification function finally developed could then be used in a dedicated analytical system to classify unknown samples rapidly and reliably. The results suggest however that the measurement of a discrete number of compounds may be sufficient for identifying persons with lung inflammation.
Piracy-free
Assured Quality
Secure Transactions
Delivery Options
Please enter pincode to check delivery time.
*COD & Shipping Charges may apply on certain items.